Top Markets
#1 Black Phoenix Black Phoenix +197.93%
#2 Islamic Coin Islamic Coin +157.91%
#3 Glidr Glidr +84.34%
#4 Gold Park Gold Park +50.78%
#5 BasedHype BasedHype +32.69%
#6 Acurast Acurast +23.82%
#7 Cryptopia Cryptopia +21.79%
#8 Quantum Resistant Ledger Quantum Resistant Ledger +19.28%
#9 Akedo Akedo +19.20%
#10 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +16.57%
Coin of the day
Black Phoenix Black Phoenix
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Viropro Inc. Viropro Inc.

Viropro Inc.

VPRO
Classifica tra le azioni #41345
Viropro Inc., a subsidiary of Alpha Biologics Limited, functions as a contract... Viropro Inc., a subsidiary of Alpha Biologics Limited, functions as a contract research and manufacturing organization (CRMO), primarily engaged in the development and production of biotherapeutic proteins aimed at treating diverse medical conditions. The company additionally facilitates the industrial-scale manufacturing of biogeneric therapeutic proteins through the licensing of its proprietary technologies, targeting illnesses like cancer, diabetes, hepatitis, and multiple sclerosis. Viropro manufactures a range of biologics drugs, including biosimilars, for use across all phases of clinical development, from pre-clinical studies through Phase I, II, and III trials. Its offerings to clients include the provision of mammalian cell proteins, such as monoclonal antibodies, recombinant proteins, and other cell-derived compounds. Notably, the firm owns three proprietary clones: two intended for insulin-related therapies and one for cancer treatment. Viropro delivers extensive contractual research and manufacturing solutions to biotech and biopharmaceutical enterprises, performing tasks such as cloning, sequencing, purification, development, validation, and production of biopharmaceutical components and finished products. The company maintains operational presences in Canada, the United Kingdom, and Malaysia, and has established a partnership with Oncobiologics, Inc. for the creation and commercialization of monoclonal antibody products. Viropro Inc. is headquartered in San Jose, California.
Prezzo delle azioni
$0.00002
Ultima sincronizzazione: 2026-08-11
Capitalizzazione di mercato
$25.40K
Variazione (1 giorno)
0.00%
Variazione (1 anno)
-80.00%
Paese
US
Scambia Viropro Inc. (VPRO)

Categoria

Healthcare
Storico del prezzo dell'azione per Viropro Inc. (VPRO)
Prezzo di chiusura più alto: $0.00 il 2026-08-01

Prezzo di chiusura più basso: $48.56 il 1995-04-01
Storico del prezzo dell'azione di Viropro Inc. dal 1995 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2026 (TTM) 0.00%
2025 -80.00%
2024 0.00%
2023 0.00%
2022 -57.03%
2021 -55.90%
2020 -27.85%
2019 -52.13%
2018 18.86%
2017 -57.35%
2016 -76.08%
2015 759.65%
2014 -90.11%
2013 126.76%
2012 -82.67%
2011 592.09%
2010 -68.15%
2009 58.59%
2008 -79.14%
2007 -83.61%
2006 0.48%
2005 -14.29%
2004 -13.88%
2003 380.61%
2002 48.03%
2001 -50.58%
2000 -55.16%
1999 -87.89%
1998 -31.96%
1997 -93.03%
1996 -93.27%
1995 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $527.87 33.33%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $873.57 35.10%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $741.84 8.49%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.08K -6.68%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $260.95 17.13%
BE